ProCE Banner Activity

Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

Podcast Episodes
In this podcast episode, experts discuss navigating therapy selection for patients with advanced hepatocellular carcinoma throughout lines of therapy. They describe which factors they consider in the absence of clinical trial data and the role of real-world evidence to support treatment decisions.

Released: August 22, 2022

Share

Faculty

Heinz-Josef Klumpen

Heinz-Josef Klumpen, MD, PhD

Staff Specialist, Medical Oncologist
Department of Medical Oncology
Amsterdam UMC
Amsterdam, The Netherlands

Chris Verslype

Chris Verslype, MD, PhD

Professor
Clinical Digestive Oncology
KULeuven
Head of Clinic
Hepatology
Digestive Oncology
U.Z. Leuven
Leuven, Belgium

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma

Faculty Disclosure

Primary Author

Heinz-Josef Klumpen, MD, PhD

Staff Specialist, Medical Oncologist
Department of Medical Oncology
Amsterdam UMC
Amsterdam, The Netherlands

Heinz-Josef Klumpen, MD, PhD: consultant/advisor/speaker: AstraZeneca, Janssen.

Chris Verslype, MD, PhD

Professor
Clinical Digestive Oncology
KULeuven
Head of Clinic
Hepatology
Digestive Oncology
U.Z. Leuven
Leuven, Belgium

Chris Verslype, MD, PhD: consultant/advisor/speaker: Bayer, Ipsen, MSD, Roche, Sirtex.